Serogroup W-135 meningococcal disease among travelers returning from Saudi Arabia--United States, 2000.

On April 9, 2000, CDC was notified by national public health agencies in several European countries of cases of serogroup W-135 meningococcal disease among pilgrims returning from the Hajj in Mecca and their close contacts. As of April 20, 2000, the New York City Department of Health had reported three cases of serogroup W-135 meningococcal disease in the United States.

[1]  K. Hyams,et al.  Protecting the health of U.S. military forces: a national obligation. , 2000, Aviation, space, and environmental medicine.

[2]  G. W. Parker,et al.  Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax. , 1999, JAMA.

[3]  T. Popović,et al.  The changing epidemiology of meningococcal disease in the United States, 1992-1996. , 1999, The Journal of infectious diseases.

[4]  G. Pugliese,et al.  Anthrax as a Biological Weapon: Medical and Public Health Management , 1999, Infection Control & Hospital Epidemiology.

[5]  L. Harrison,et al.  Group A meningococcal carriage in travelers returning from Saudi Arabia. , 1988, JAMA.

[6]  Field Evaluation of a Human Anthrax Vaccine. , 1962, American journal of public health and the nation's health.

[7]  Essie Page,et al.  District of Columbia , 1896, The Journal of Comparative Medicine and Veterinary Archives.